Everett Neville - 27 Feb 2026 Form 4 Insider Report for Cigna Group (CI)

Role
Officer
Signature
Tyler Gratton, attorney-in-fact
Issuer symbol
CI
Transactions as of
27 Feb 2026
Net transactions value
-$899,206
Form type
4
Filing time
03 Mar 2026, 19:18:57 UTC
Previous filing
09 Apr 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Neville Everett Officer 900 COTTAGE GROVE RD, BLOOMFIELD Tyler Gratton, attorney-in-fact 02 Mar 2026 0001641142

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CI Common Stock, $.01 Par Value Award $0 +2,602 +74% $0.000000 6,111 27 Feb 2026 Direct F1
transaction CI Common Stock, $.01 Par Value Award $0 +2,678 +44% $0.000000 8,789 27 Feb 2026 Direct F2
transaction CI Common Stock, $.01 Par Value Tax liability $253,907 -883 -10% $287.55 7,906 27 Feb 2026 Direct F3
transaction CI Common Stock, $.01 Par Value Tax liability $148,663 -517 -6.5% $287.55 7,389 27 Feb 2026 Direct F4
transaction CI Common Stock, $.01 Par Value Sale $496,636 -1,719 -23% $288.91 5,670 02 Mar 2026 Direct F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CI Employee Stock Option (Right to Buy) Award $0 +4,127 $0.000000 4,127 27 Feb 2026 Common Stock, $.01 Par Value 4,127 $287.55 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2023-2025 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals.
F2 These restricted shares vest in three equal annual installments beginning March 1, 2027.
F3 Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares.
F4 Represents shares withheld to satisfy tax obligations upon vesting of restricted shares.
F5 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2025.
F6 This option vests in three equal annual installments beginning March 1, 2027.